Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from streptococcus salivarius 5M6c isolated from a healthy infant

Applied and Environmental Microbiology

Volumn 78, Issue 2, 2012, Pages 402-410

  Birri, Dagim Jirata ^a   Brede, Dag Anders ^a   Nes, Ingolf F ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BACTERIOCINS; BIOLOGICAL AGENTS; CYCLASES; DNA SEGMENTS; GENES ENCODING; GRAM-POSITIVE BACTERIUM; HISTIDINE KINASE; HUMAN PATHOGENS; IMMUNITY GENES; IMMUNITY PROTEINS; LANTIBIOTICS; PROBIOTIC BACTERIA; RESPONSE REGULATORS; SENSITIVE INDICATOR; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

AMINO ACIDS; ENCODING (SYMBOLS); ENZYMES; GENE ENCODING; PEPTIDES;

BACTERIA;

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIOCIN; PEPTIDE; TRYPSIN;

AMINO ACID; ANTIBIOTICS; BACTERIUM; BIOCONTROL AGENT; BIOTECHNOLOGY; CHILD HEALTH; DISEASE CONTROL; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNITY; PATHOGEN; PEPTIDE; PROBIOTICS; PROTEIN; PUBLIC HEALTH; PURIFICATION;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; GENETICS; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; BIOSYNTHETIC PATHWAYS; DNA, BACTERIAL; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; PEPTIDES; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS; TRYPSIN;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS;

EID: 84855753849     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.06588-11     Document Type: Article

References (57)

1. Afolabi OA, et al. 1985. A preliminary survey of aerobic bacteria in breast milk of mothers from the low-income group in Nigeria. Trop. Geogr. Med. 37:245-249.
2. Asaduzzaman SM, Sonomoto K. 2009. Lantibiotics: diverse activities and unique modes of action. J. Biosci. Bioeng. 107:475-487.
3. Bierbaum G, Sahl HG. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10:2-18.
4. Birri DJ, Brede DA, Forberg T, Holo H, Nes IF. 2010. Molecular and genetic characterization of a novel bacteriocin locus in Enterococcus avium isolates from infants. Appl. Environ. Microbiol. 76:483-492.
5. Breukink E, de Kruijff B. 2006. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5:321-332.
6. Buchman GW, Banerjee S, Hansen JN. 1988. Structure, expression, and evolution of a gene encoding the precursor of nisin, a small protein antibiotic. J. Biol. Chem. 263:16260-16266.
7. Castiglione F, et al. 2007. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry 46:5884-5895.
8. Cleveland J, Montville TJ, Nes IF, Chikindas ML. 2001. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71:1-20.
9. Collins B, Cotter PD, Hill C, Ross RP. 2010. Application of lactic acid bacteria-produced bacteriocins, p. 89-109. In Mozzi F, Raya RR, and Vignolo GM (ed), Biotechnology of lactic acid bacteria: novel applications. Blackwell, Hoboken, NJ.
10. Corr SC, et al. 2007. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U. S. A. 104:7617-7621.
11. de Kwaadsteniet M, Ten Doeschate K, Dicks LM. 2008. Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus). Appl. Environ. Microbiol. 74:547-549.
12. Dicks L, Knoetze H, van Reenen C. 2009. Otitis media: a review, with a focus on alternative treatments. Probiotics Antimicrob. Proteins 1:45-59.
13. Diep DB, Godager L, Brede D, Nes IF. 2006. Data mining and characterization of a novel pediocin-like bacteriocin system from the genome of Pediococcus pentosaceus ATCC 25745. Microbiology 152:1649-1659.
14. Dierksen KP, Moore CJ, Inglis M, Wescombe PA, Tagg JR. 2007. The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue. FEMS Microbiol. Ecol. 59:584-591.
15. Draper LA, Ross RP, Hill C, Cotter PD. 2008. Lantibiotic immunity. Curr. Protein. Pept. Sci. 9:39-49.
16. Engelke G, Gutowski-Eckel Z, Hammelmann M, Entian KD. 1992. Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein. Appl. Environ. Microbiol. 58:3730-3743.
17. Engelke G, et al. 1994. Regulation of nisin biosynthesis and immunity in Lactococcus lactis 6F3. Appl. Environ. Microbiol. 60:814-825.
18. Field D, Connor PM, Cotter PD, Hill C, Ross RP. 2008. The generation of nisin variants with enhanced activity against specific Gram-positive pathogens. Mol. Microbiol. 69:218-230.
19. Field D, et al. 2010. Studies with bioengineered nisin peptides highlight the broad-spectrum potency of nisin V. Microb. Biotechnol. 3:473-486.
20. Holo H, Nilssen O, Nes IF. 1991. Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris: isolation and characterization of the protein and its gene. J. Bacteriol. 173:3879-3887.
21. Hyatt D, et al. 2010. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 11:119.
22. Hyink O, et al. 2007. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl. Environ. Microbiol. 73:1107-1113.
23. Kang JG, Kim SH, Ahn TY. 2006. Bacterial diversity in the human saliva from different ages. J. Microbiol. 44:572-576.
24. Kleerebezem M. 2004. Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis. Peptides 25: 1405-1414.
25. Kubota H, et al. 2010. Detection of human intestinal catalase-negative, Gram-positive cocci by rRNA-targeted reverse transcription-PCR. Appl. Environ. Microbiol. 76:5440-5451.
26. Kuipers OP, Beerthuyzen MM, de Ruyter PG, Luesink EJ, de Vos WM. 1995. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J. Biol. Chem. 270:27299-27304.
27. Kuipers OP, Beerthuyzen MM, Siezen RJ, De Vos WM. 1993. Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur. J. Biochem. 216:281-291.
28. Maeda Y, et al. 2011. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J. Cyst. Fibros. 10: 133-139.
29. Marchler-Bauer A, et al. 2011. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39:D225-D229.
30. Meyer HE, et al. 1994. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal. Biochem. 223:185-190.
31. Mulders JW, Boerrigter IJ, Rollema HS, Siezen RJ, de Vos WM. 1991. Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur. J. Biochem. 201:581-584.
32. Nes IF, et al. 1996. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie Van Leeuwenhoek 70:113-128.
33. O'Shea EF, et al. 2009. Characterization of enterocin- and salivaricinproducing lactic acid bacteria from the mammalian gastrointestinal tract. FEMS Microbiol. Lett. 291:24-34.
34. O'Shea EF, O'Connor PM, Cotter PD, Ross RP, Hill C. 2010. Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P. Appl. Environ. Microbiol. 76:5356-5362.
35. Park HK, et al. 2005. Molecular analysis of colonized bacteria in a human newborn infant gut. J. Microbiol. 43:345-353.
36. Qi F, Chen P, Caufield PW. 1999. Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl. Environ. Microbiol. 65:3880-3887.
37. Rea MC, et al. 2011. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl. 1):4639-4644.
38. Rea MC, Ross RP, Cotter PD, Hill C. 2011. Classification of bacteriocins from Gram-positive bacteria. In Drider D and Rebuffat S (ed), Prokaryotic antimicrobial peptides: from genes to applications. Springer, New York, NY.
39. Ross KF, Ronson CW, Tagg JR. 1993. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl. Environ. Microbiol. 59:2014-2021.
40. Rozkiewicz D, et al. 2006. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population. Adv. Med. Sci. 51(Suppl. 1):191-195.
41. Rutherford K, et al. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945.
42. Sahl HG, Jack RW, Bierbaum G. 1995. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur. J. Biochem. 230:827-853.
43. Schmitz S, Hoffmann A, Szekat C, Rudd B, Bierbaum G. 2006. The lantibiotic mersacidin is an autoinducing peptide. Appl. Environ. Microbiol. 72:7270-7277.
44. Sherman JM, Niven CF, Smiley KL. 1943. Streptococcus salivarius and other non-hemolytic streptococci of the human throat. J. Bacteriol. 45:249-263.
45. Siezen RJ, et al. 2010. Complete genome sequence of Lactococcus lactis subsp. lactis KF147, a plant-associated lactic acid bacterium. J. Bacteriol. 192:2649-2650.
46. Solis G, de Los Reyes-Gavilan CG, Fernandez N, Margolles A, Gueimonde M. 2010. Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut. Anaerobe 16:307-310.
47. Tagg J. 2009. Streptococcal bacteriocin-like inhibitory substances: some personal insights into the bacteriocin-like activities produced by streptococci good and bad. Probiotics Antimicrob. Proteins 1:60-66.
48. Tagg JR. 2004. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J. Med. Res. 119(Suppl.):13-16.
49. Upton M, Tagg JR, Wescombe P, Jenkinson HF. 2001. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J. Bacteriol. 183:3931-3938.
50. van de Guchte M, van der Vossen JM, Kok J, Venema G. 1989. Construction of a lactococcal expression vector: expression of hen egg white lysozyme in Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 55:224-228.
51. Watanabe T, Shimohashi H, Kawai Y, Mutai M. 1981. Studies on streptococci. I. Distribution of fecal streptococci in man. Microbiol. Immunol. 25:257-269.
52. Wescombe PA, Heng NC, Burton JP, Chilcott CN, Tagg JR. 2009. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 4:819-835.
53. Wescombe PA, et al. 2006. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva. Appl. Environ. Microbiol. 72:1459-1466.
54. Wescombe PA, et al. 2011. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology 157:1290-1299.
55. Willey JM, van der Donk WA. 2007. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.
56. Wirawan RE, Klesse NA, Jack RW, Tagg JR. 2006. Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl. Environ. Microbiol. 72:1148-1156.
57. Yoneyama F, Fukao M, Zendo T, Nakayama J, Sonomoto K. 2008. Biosynthetic characterization and biochemical features of the third natural nisin variant, nisin Q., produced by Lactococcus lactis 61-14. J. Appl. Microbiol. 105:1982-1990.